These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18514200)

  • 1. Prostanoid and isoprostanoid pathways in atherogenesis.
    Praticò D
    Atherosclerosis; 2008 Nov; 201(1):8-16. PubMed ID: 18514200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular biology of eicosanoids and atherogenesis.
    Praticò D; Dogné JM
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1079-89. PubMed ID: 19764861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.
    Dogné JM; Hanson J; Pratico D
    Trends Pharmacol Sci; 2005 Dec; 26(12):639-44. PubMed ID: 16243403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostanoids and prostanoid receptors in signal transduction.
    Bos CL; Richel DJ; Ritsema T; Peppelenbosch MP; Versteeg HH
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1187-205. PubMed ID: 15109566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenases, prostanoids, and tumor progression.
    Wang MT; Honn KV; Nie D
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):525-34. PubMed ID: 17763971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular biology of the isoprostanes.
    Cracowski JL; Devillier P; Durand T; Stanke-Labesque F; Bessard G
    J Vasc Res; 2001; 38(2):93-103. PubMed ID: 11316945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.
    Yuhki K; Kojima F; Kashiwagi H; Kawabe J; Fujino T; Narumiya S; Ushikubi F
    Pharmacol Ther; 2011 Feb; 129(2):195-205. PubMed ID: 20920529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoids as pharmacological targets in COPD and asthma.
    Rolin S; Masereel B; Dogné JM
    Eur J Pharmacol; 2006 Mar; 533(1-3):89-100. PubMed ID: 16458293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.
    Spiteller G
    Mol Nutr Food Res; 2005 Nov; 49(11):999-1013. PubMed ID: 16270286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
    Capra V; Bäck M; Barbieri SS; Camera M; Tremoli E; Rovati GE
    Med Res Rev; 2013 Mar; 33(2):364-438. PubMed ID: 22434418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insights into the role of prostanoids in atherosclerotic vascular disease.
    Reiss AB; Edelman SD
    Curr Vasc Pharmacol; 2006 Oct; 4(4):395-408. PubMed ID: 17073704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases.
    Alfranca A; Iñiguez MA; Fresno M; Redondo JM
    Cardiovasc Res; 2006 Jun; 70(3):446-56. PubMed ID: 16458868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
    Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
    Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostanoid receptors: subtypes and signaling.
    Breyer RM; Bagdassarian CK; Myers SA; Breyer MD
    Annu Rev Pharmacol Toxicol; 2001; 41():661-90. PubMed ID: 11264472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis.
    Leonarduzzi G; Gamba P; Gargiulo S; Biasi F; Poli G
    Free Radic Biol Med; 2012 Jan; 52(1):19-34. PubMed ID: 22037514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of isoprostanes and prostanoids on porcine small intestine.
    Unmack MA; Rangachari PK; Skadhauge E
    J Pharmacol Exp Ther; 2001 Feb; 296(2):434-41. PubMed ID: 11160628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprostanes and lung vascular pathology.
    Janssen LJ
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):383-9. PubMed ID: 18441279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.